Also, Verdurand et al. [42] analyzed antemortem CSF samples and reported six (14.3%) AD cases that tested positive in α-syn SAA, from which five were later reclassified as AD/LBP upon review of clinical records. This evidence concerns the gene LBP and Alzheimer disease.